Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Trial of E7777 in Combination With CHOP Compared With CHOP Alone for the First-Line Treatment of Peripheral T-cell Lymphoma

NCT01355783 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT01355783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01355783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Trial of E7777 in Combination With CHOP Compared With CHOP Alone for the First-Line Treatment of Peripheral T-cell Lymphoma
Lead sponsor
Eisai Inc.
Phase
Phase 3
Overall status
Withdrawn
Start date
March 31, 2011
Completion date
November 30, 2014
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral t-cell lymphoma